1. 03 Jul 2014  |  Global  |  Market Research

    A Global Product and Pipeline Analysis of Antiretroviral Drug Development for the Treatment of HIV/AIDS

    Antiretroviral Combinations Continue to Transform the Treatment Landscape

    This research service focuses on antiviral/antiretroviral therapeutics for the treatment of HIV/AIDS. A product and pipeline assessment is provided for marketed and investigational products and combination regimens for the treatment of HIV infection. Segmentation by drug class is provided along with additional supporting information such as clinica...

    $3,950.00
  2. 26 Mar 2013  |  Global  |  Market Research

    Strategic Analysis of Antiviral Drug Development for Viral Hepatitis and HIV/AIDS

    Persistent Unmet Need Fuels Antiviral Drug Development for Bloodborne Pathogens

    This research service focuses on antiviral/antiretroviral therapeutics for the treatment of infection with blood-borne pathogens of current global interest, specifically viral hepatitis and HIV/AIDS. A product and pipeline assessment is provided for marketed and investigational products and combination regimens for the treatment of HBV, HCV, and H...

    $1,500.00
  3. 23 Jan 2013  |  North America  |  Market Research

    Analysis of the European HIV Drugs Market

    Increasing Adoption of Oral Combination-pills for Treatment Boosts Market Growth

    Dyslipidemia exists in many forms and is prevalent in developed regions. Although many patients with moderately elevated lipids are well served by available therapies, there is a significant patient population for whom these therapies are inappropriate or inadequate, thereby prompting development of innovative therapies to fill the gaps. This res...

    $4,950.00
  4. 07 Dec 2012  |  Europe  |  Market Research

    Analysis of European HIV Diagnostics Market

    Increasing Adoption of HIV Nucleic Acid Testing (NAT) and Automation Spurs Market Growth.

    The increase in HIV awareness among people has led to the demand for effective diagnostic products and solutions. As a result, some new products based on NAT technology and non-NAT technology platforms are being developed. This research service analyses the HIV diagnostics market in Europe, particularly, HIV NAT diagnostics and HIV Immunodiagnostic...

    $4,950.00
  5. 11 Jun 2009  |  Europe  |  Market Research

    European HIV/AIDS and Hepatitis B/C Molecular Diagnostics Market

     

    This research service analyses the revenue potential for HIV/AIDS and Hepatitis B/C molecular diagnostics markets in major western European countries. It also gives the overview of the market in these regions together with market drivers,restraints and challenges in the whole Europe. Together it recommends strategies for the players in these market...

    $4,950.00
  6. 18 Apr 2009  |  Europe  |  Market Research

    European HIV/AIDS Therapeutics Markets

     

    This research service analyses the rapidly evolving European HIV/AIDS therapeutic market. The research service provides revenue estimation and forecast based on the factors that are expected drive and restrain the market in the forecast period. Challenges faced by the industry are analysed and strategic recommendations are discussed based on the ...

    $4,950.00
  7. 01 Feb 2005  |  Global  |  Market Research

    Strategic Analysis of Global HIV Diagnostics and Monitoring Markets

     

    This research service analyzes the changing dynamics within the global HIV diagnostics and monitoring. Included in this research service are revenue forecasts, unit shipment, market and technology trends, major issues and challenges, analysis of growth opportunities, and competitive landscape. The market is segmented by - HIV Antibody Screening, ...

    $3,950.00
  8. 28 Jun 2004  |  Global  |  Market Research

    Strategic Analysis of World HIV Therapeutics Markets

     

    This research service analyzes the changing dynamics within the global HIV therapeutics market. Included in this research service are revenue forecasts, market shares, patient forecasts, market and technology trends, factors affecting market growth, major issues and challenges, analysis of growth opportuniters, and individual product forecasts and...

    $3,950.00
  9. 27 Jan 2003  |  North America  |  Market Research

    U.S. HIV/AIDS Therapies Markets

     

    The U.S. HIV/AIDS Therapies Markets report covers the various antiretroviral (ARV) drugs that are currently available in the U.S. namely, NRTIs, PIs and NNRTIs. The report also covers the pipeline drugs from the existing and novel ARV categories, and the HIV vaccines pipeline. Frost & Sullivan Market Engineering Analysis, major market/technology tr...

    $2,450.00
  10. 23 Dec 2002  |  North America  |  Market Research

    U.S. HIV Diagnostics and Monitoring Markets

     

    The U.S. HIV Diagnostics and Monitoring Market report focuses on the dynamic and increasingly complex area of HIV diagnostics assays implemented to facilitate disease management. This report covers the Diagnostics, Viral Load Monitoring, Genotyping/Phenotyping, and CD4/CD8 Cell Monitoring segments of the market. This report provides an in-depth ana...

    $2,450.00